In vitro controlled release of Rifampicin through liquid-crystalline folate nanoparticles

- Controlled release of Rifampicin by changing nanoparticle size and cross-linking.
- Self-assembled structure offers high encapsulation (80-90%).
- Active cellular uptake by alveolar macrophages.
- Low/minimal cytotoxicity to macrophages.